Manufacturing sites
Hanxin's pharm manufacturing sites, located in Nanjing Economic and Technological Development Zone, cover a total area of 55,000 square meters, 13 GMP-standard manufacturing lines, with the capability to produce various dosage forms, including ointments, gels, suppositories, injections, granules, capsules, tablets, and penicillin solid formulations, with leading domestic levels. More than 30 projects have been commercialized in China.
Milestones
More than 30 products with continuous manufacturing over 30 years includingcreams, gels, suppositories, non sterile injections, solid oral powder suspensions, granules, capsule formulations, tablets, etc., covering the areas of dermatology, cardiology and
cerebrovascular diseases, pneumology, gastrology, gynecology, and pediatrics.
Advantages:
GMP：
Commercial manufacturing lines that comply with China's GMP requirements.
Our services：
Provides CDMO services from pilot-scale to commercial manufacturing.
Compliance service guarantee:
We have a professional, standardized, and normative service guarantee system that fully complies with the ChP and GMP throughout the entire cycle.
Professional team guarantee:
Experienced CDMO executive team with 30 years of production capacity and quality management experience in various dosage forms such as ointment, gel, suppository, injection, granules, penicillin solid preparation, and capsule.
International perspective:
In the future, we will enter the US market and apply for FDA approval for topical and oral preparations.
In the future, we will enter the US market and apply for FDA approval for topical and oral preparations.
|
|
